303 related articles for article (PubMed ID: 31214201)
1. Thrombospondin-1/CD47 Interaction Regulates Th17 and Treg Differentiation in Psoriasis.
Rodríguez-Jiménez P; Chicharro P; Llamas-Velasco M; Cibrian D; Trigo-Torres L; Vara A; Jiménez-Fernández M; Sevilla-Montero J; Calzada MJ; Sánchez-Madrid F; de la Fuente H; Daudén E
Front Immunol; 2019; 10():1268. PubMed ID: 31214201
[TBL] [Abstract][Full Text] [Related]
2. Elevated postinjury thrombospondin 1-CD47 triggering aids differentiation of patients' defective inflammatory CD1a+dendritic cells.
Bandyopadhyay G; Bandyopadhyay S; Bankey PE; Miller-Graziano CL
J Leukoc Biol; 2014 Nov; 96(5):797-807. PubMed ID: 25001859
[TBL] [Abstract][Full Text] [Related]
3. Reduced CD18 levels drive regulatory T cell conversion into Th17 cells in the CD18hypo PL/J mouse model of psoriasis.
Singh K; Gatzka M; Peters T; Borkner L; Hainzl A; Wang H; Sindrilaru A; Scharffetter-Kochanek K
J Immunol; 2013 Mar; 190(6):2544-53. PubMed ID: 23418628
[TBL] [Abstract][Full Text] [Related]
4. IL-33 changes CD25
Park SH; Jung HJ; Kim TS
Immunol Lett; 2020 Feb; 218():5-10. PubMed ID: 31863784
[TBL] [Abstract][Full Text] [Related]
5. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47.
Kamijo H; Miyagaki T; Takahashi-Shishido N; Nakajima R; Oka T; Suga H; Sugaya M; Sato S
Leukemia; 2020 Mar; 34(3):845-856. PubMed ID: 31712778
[TBL] [Abstract][Full Text] [Related]
7. Correlation analysis of Treg/Th17 cells and related cytokines in patients with psoriasis vulgaris.
Qu T; Mei C; Zeng Y; Li L; Duan X
J Tradit Chin Med; 2019 Oct; 39(5):700-706. PubMed ID: 32186120
[TBL] [Abstract][Full Text] [Related]
8. Leptin deficiency impairs maturation of dendritic cells and enhances induction of regulatory T and Th17 cells.
Moraes-Vieira PM; Larocca RA; Bassi EJ; Peron JP; Andrade-Oliveira V; Wasinski F; Araujo R; Thornley T; Quintana FJ; Basso AS; Strom TB; Câmara NO
Eur J Immunol; 2014 Mar; 44(3):794-806. PubMed ID: 24271843
[TBL] [Abstract][Full Text] [Related]
9. MiR-200a expression in CD4+ T cells correlates with the expression of Th17/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study.
Wang XY; Chen XY; Li J; Zhang HY; Liu J; Sun LD
Biomed Pharmacother; 2017 Sep; 93():1158-1164. PubMed ID: 28738533
[TBL] [Abstract][Full Text] [Related]
10. IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis Patients.
Shi Y; Chen Z; Zhao Z; Yu Y; Fan H; Xu X; Bu X; Gu J
Front Immunol; 2019; 10():1865. PubMed ID: 31440249
[No Abstract] [Full Text] [Related]
11. Photo(chemo)therapy reduces circulating Th17 cells and restores circulating regulatory T cells in psoriasis.
Furuhashi T; Saito C; Torii K; Nishida E; Yamazaki S; Morita A
PLoS One; 2013; 8(1):e54895. PubMed ID: 23365685
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice.
Contreras Ruiz L; Mir FA; Turpie B; Masli S
Clin Exp Immunol; 2017 Apr; 188(1):86-95. PubMed ID: 28033649
[TBL] [Abstract][Full Text] [Related]
13. Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosus.
Estrada-Capetillo L; Hernández-Castro B; Monsiváis-Urenda A; Alvarez-Quiroga C; Layseca-Espinosa E; Abud-Mendoza C; Baranda L; Urzainqui A; Sánchez-Madrid F; González-Amaro R
Clin Dev Immunol; 2013; 2013():584303. PubMed ID: 24288552
[TBL] [Abstract][Full Text] [Related]
14. Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.
Kukreja A; Radfar S; Sun BH; Insogna K; Dhodapkar MV
Blood; 2009 Oct; 114(16):3413-21. PubMed ID: 19661269
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.
Miller TW; Kaur S; Ivins-O'Keefe K; Roberts DD
Matrix Biol; 2013 Aug; 32(6):316-24. PubMed ID: 23499828
[TBL] [Abstract][Full Text] [Related]
16. Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+ CD25- T cells in response to inflammation.
Grimbert P; Bouguermouh S; Baba N; Nakajima T; Allakhverdi Z; Braun D; Saito H; Rubio M; Delespesse G; Sarfati M
J Immunol; 2006 Sep; 177(6):3534-41. PubMed ID: 16951312
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response.
Yan L; Hu F; Yan X; Wei Y; Ma W; Wang Y; Lu S; Wang Z
J Mol Med (Berl); 2016 Sep; 94(9):1063-79. PubMed ID: 27052830
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-derived thrombospondin-1 is critical for the generation of the ocular surface Th17 response to desiccating stress.
Gandhi NB; Su Z; Zhang X; Volpe EA; Pelegrino FS; Rahman SA; Li DQ; Pflugfelder SC; de Paiva CS
J Leukoc Biol; 2013 Dec; 94(6):1293-301. PubMed ID: 23983225
[TBL] [Abstract][Full Text] [Related]
19. 3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17/Treg cell differentiation and suppressing dendritic cell activation.
Okano T; Saegusa J; Nishimura K; Takahashi S; Sendo S; Ueda Y; Morinobu A
Sci Rep; 2017 Feb; 7():42412. PubMed ID: 28186160
[TBL] [Abstract][Full Text] [Related]
20. T(H)1, T(H)2, and T(H)17 cells instruct monocytes to differentiate into specialized dendritic cell subsets.
Alonso MN; Wong MT; Zhang AL; Winer D; Suhoski MM; Tolentino LL; Gaitan J; Davidson MG; Kung TH; Galel DM; Nadeau KC; Kim J; Utz PJ; Söderström K; Engleman EG
Blood; 2011 Sep; 118(12):3311-20. PubMed ID: 21813450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
